Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Doug P. Nesta"'
Autor:
John H. A. Amery, Stefan Andreas Lange, Hill Malcolm Leithhead, Robert Simler, Leigh Dixon, Frank Gielen, Cinzia Gazziola, Doug P. Nesta, Jale Muslehiddinoglu, Kirsten Storch, Claudia Mueller, Jeremy D. Prail, Anna L. Watson
Publikováno v:
Nucleic Acid Therapeutics
The most common approach for the manufacture of oligonucleotides includes isolation of the active pharmaceutical ingredient (API) via lyophilization to provide a solid product, which is then dissolved to provide an aqueous formulation. It is well kno
Autor:
James D. Colandene, Shubhadra N. Singh, Ning Wang, Doug P. Nesta, Rachel Forcino, Valeriy Bondar, Swati Kumar
Publikováno v:
International journal of pharmaceutics. 552(1-2)
The study explores new benefits of controlled ice nucleation during lyophilization. A highly concentrated monoclonal antibody product was lyophilized using conventional (uncontrolled) and controlled ice nucleation freezing and the processes were comp
Autor:
Karoline Bechtold-Peters, Jeffrey T. Blue, Hanns-Christian Mahler, Mary E.M. Cromwell, Michel Awwad, Satish K. Singh, Thomas Spitznagel, Doug P. Nesta, Danny K. Chou, Hans-Juergen Krause, Nataliya Afonina, Brian K. Meyer, Linda O. Narhi
Publikováno v:
Journal of Pharmaceutical Sciences. 99:3302-3321
Concern around the lack of monitoring of proteinaceous subvisible particulates in the 0.1-10 microm range has been heightened (Carpenter et al., 2009, J Pharm Sci 98: 1202-1205), primarily due to uncertainty around the potential immunogenicity risk f